Latest Renewables News

Mont Royal Resources has unveiled an updated Preliminary Economic Assessment for its Ashram Rare Earths Project, confirming robust economics and a long mine life with strategic importance for Western critical minerals supply chains.

Richmond Vanadium Technology (ASX: RVT) has signed a binding collaboration with RKP Global to jointly develop vanadium flow battery and long-duration energy storage projects in Australia, advancing its mine-to-battery strategy.

Steel & Tube has secured a one-year extension on its ANZ banking facilities, underpinning financial stability as trading conditions soften due to geopolitical tensions and sector-specific pressures.

Ozz Resources aims to raise up to AUD 5 million through a public offer to fund the acquisition of Sulphide Minerals and exploration of the Bedaburra Project, pending ASX re-admission and shareholder approval.

Legacy Minerals has kicked off an 885m drilling campaign at McMahons Reef within its Harden Gold Project, funded by Hill Tops Gold under a joint venture. Meanwhile, Rio Tinto Exploration has withdrawn from the Thomson Project, returning 100% ownership to Legacy Minerals.

North Stawell Minerals has launched a 600-800 metre diamond drilling program at its Darlington Project, aiming to extend previously identified high-grade gold zones that echo historic Victorian gold trends.

Brazilian Critical Minerals (ASX: BCM) reports robust magnesium sulphate leach results from its 2025 drilling at the Ema project, validating key assumptions for a long-life, low-cost rare earth operation.

Monadelphous has landed a $380 million contract to build and install gas turbine units at CS Energy’s Brigalow Peaking Power Plant in Queensland, marking a significant step in the company’s energy infrastructure pipeline.

Ryman Healthcare nearly doubles operating profitability and generates positive free cash flow for the first time in over a decade, while shifting strategy toward sustainable growth and targeting dividend returns by FY28.

Frontier Energy has locked in firm commitments for a $110 million equity raise to fund Stage One of its Waroona solar-battery project, advancing alongside senior debt financing and contract finalisations.

Island Pharmaceuticals has kicked off GMP manufacturing of its antiviral Galidesivir to support late-stage Marburg virus studies under the FDA Animal Rule, marking a key step towards regulatory submission and biodefence readiness.

Viridis Mining locks in a fixed-price, turnkey contract for critical power infrastructure at its Colossus Rare Earth Project, aligning with the company’s Final Investment Decision and production timelines.